• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with strongest adhd medication for adults face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how does medication for adhd work long-term exposure to these drugs may affect the foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological disorders such as hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the benefits of taking them against the potential risks to the fetus. The doctors don't have the information to provide clear recommendations, but can provide information about risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not face an increased risk of fetal heart malformations or major birth defects that are structural. Researchers used a large population-based case control study to compare the incidence of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to ensure that the classification was correct and to reduce any bias.

The study of the researchers was not without limitations. The researchers were unable in the beginning to differentiate the effects triggered by the medication from the disorder. This limitation makes it difficult for researchers to establish whether the small associations observed among the exposed groups were due to the use of medications or affected by the presence of comorbidities. The researchers also did not study long-term outcomes for the offspring.

The study revealed that infants whose mothers had taken ADHD medication during pregnancy were at a slightly higher chance of being admitted to the neonatal care unit (NICU) in comparison to mothers who didn't take any medication during pregnancy or discontinued taking their medication prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the increased risk for admission was not found to be affected by the type of stimulant medication was used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an increased chance of having a caesarean delivery or having a baby with a low Apgar score (less than 7). These increases did not appear to be influenced by the kind of medication used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medications in early pregnancies may be offset by the greater benefits for mother and baby of continuing treatment for the woman’s disorder. Physicians should discuss this with their patients and, where possible, help them develop strategies to improve their coping abilities that can lessen the effects of her disorder on her daily functioning and relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to keep treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are usually made without clear and authoritative evidence. Instead, doctors have to take into account their own experience, the experience of other doctors and the research that has been conducted on the subject.

Particularly, the subject of potential risks to the baby can be a challenge. The research on this issue is based on observation rather than controlled studies and a lot of the results are conflicting. Additionally, the majority of studies limit their analysis to live births, which could underestimate severe teratogenic effects that lead to abortion or termination of the pregnancy. The study discussed in the journal club addresses these shortcomings by analyzing both the data from deceased and live births.

Conclusion: While some studies have found a positive correlation between ADHD medications and certain birth defects however, other studies haven't shown such a relationship. The majority of studies show that there is a neutral, or somewhat negative, effect. As a result, a careful risk/benefit assessment is required in every instance.

It isn't easy, but not impossible for women with ADHD to stop taking their medication. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medication adults ADHD medications during pregnancy can increase depression and feelings of isolation. Additionally, the loss of medication can interfere with the ability to do work-related tasks and safely drive, which are important aspects of daily life for many people suffering from ADHD.

She suggests that women who aren't sure whether to continue taking the medication or stop due to pregnancy educate family members, colleagues, and friends about the condition, the impact on daily functioning and the advantages of staying on the current treatment plan. In addition, educating them can help the woman feel supported when she is struggling with her decision. It is important to remember that some drugs can be absorbed through the placenta so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the drug can be transferred to the child.

Risk of Birth Defects

As the use and use of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (ADHD) increases the concern over the possible effects of the drugs on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing information on this topic. Utilizing two huge data sets researchers were able examine more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that although the overall risk is low, the first trimester ADHD exposure to medication was associated with slightly higher rates of certain heart defects, like ventriculoseptal defect.

The researchers behind the study found no association between early use of medication and congenital abnormalities like facial clefting, or club foot. The findings are in line with previous studies that have shown a small but significant increase in the risk of cardiac malformations among women who began taking ADHD medications prior to the birth of their child. The risk was higher in the latter half of pregnancy, when many women are forced to stop taking their ADHD medications.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean delivery, have an insufficient Apgar after delivery and have a baby that needed help breathing at birth. The researchers of the study could not eliminate bias due to selection because they restricted the study to women who did not have any other medical conditions that might have contributed to the findings.

The researchers hope their study will help inform the clinical decisions of doctors who encounter pregnant women. The researchers recommend that, while discussing risks and benefits are important, the choice regarding whether or not to stop taking medication should be based on the severity of each woman's ADHD symptoms and her requirements.

The authors also caution that, while stopping the medication is an alternative, it is not a recommended practice because of the high incidence of depression and other mental health issues for women who are expecting or postpartum. Additionally, the research suggests that women who decide to stop taking their medication are more likely to experience a difficult time getting used to life without them following the baby's arrival.

Nursing

It can be a stressful experience to become a mom. Women suffering from ADHD may face a lot of challenges when they must deal with their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to a new routine. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications used for adhd are absorbed by breast milk in low amounts, therefore the risk to infant who is breastfeeding is low. However, the frequency of exposure to medication by the newborn may differ based on the dosage, frequency it is administered, and the time of day it is administered. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn isn't yet fully known.

Some doctors may stop taking stimulant medications during a woman's pregnancy due to the lack of research. It is a difficult decision for the woman, who must weigh the benefits of her medication against the risk to the embryo. As long as there is no more information, doctors should inquire with all pregnant patients about their history of ADHD and whether they are taking or planning to take medication during the perinatal time.

A growing number of studies have proven that most effective adhd medication for adults women can safely continue to take their adhd medication pregnancy (rogers-jonassen.blogbright.net) medication during pregnancy and while breastfeeding. As a result, more and more patients choose to do so, and in consultation with their doctor they have discovered that the benefits of keeping their current medication exceed any risk.

It is crucial for women suffering from ADHD who are considering breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation should also be offered to help pregnant women suffering from ADHD recognize their symptoms and the root cause and learn about treatment options and strengthen existing coping strategies. This should include a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, and monitoring for signs of deterioration, and, if needed modifications to the medication regimen.